Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients

被引:75
作者
Bammens, B
Evenepoel, P
Verbeke, K
Vanrenterghem, Y
机构
[1] Univ Hosp Gasthuisberg, Dept Med, Div Nephrol, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Lab Digest & Absorpt, B-3000 Louvain, Belgium
关键词
p-Cresol; protein-bound solutes; peritoneal dialysis (PD); clearances; residual renal function;
D O I
10.1053/j.ajkd.2005.05.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Residual renal function (RRF) contributes substantially to the adequacy of peritoneal dialysis (PD). In the presence of RRF, maintenance of an adequate fluid balance is facilitated, level of systemic inflammation is lower, and renal endocrine functions are preserved. The beneficial impact of RRF also may be related to the preservation of specific renal elimination mechanisms, such as tubular metabolism or secretion, which are crucial for the removal of some uremic retention solutes. Methods: Time profiles of peritoneal and renal clearances of urea nitrogen (60 d), creatinine (113 d), phosphate (96 d), the middle molecule beta(2)-microglobulin (beta M-2; 11.8 kd), and the protein-bound solute p-cresol (108 d) were investigated prospectively in 24 incident PD patients. Data were analyzed by using the linear mixed models procedure. Results: During a median follow-up of 7.2 months (range, 5.6 to 8.6 months), RRF (P = 0.001) and 24-hour urine volume (P = 0.004) declined significantly. Twenty-four-hour peritoneal drainage volume increased (P < 0.0001). Renal clearances of urea nitrogen (P = 0.0002), creatinine (P = 0.001), and phosphate (P = 0.001) decreased. Peritoneal clearances of these solutes increased (P = 0.002, P < 0.0001, and P < 0.0001, respectively). There was a decline in renal clearances of beta M-2 (P = 0.0004) and p-cresol (P < 0.0001). No change in peritoneal clearances of these solutes was noted (P = 0.188 and P = 0.559, respectively). Conclusion: Increasing PD dose may compensate for deteriorating RRF with respect to the elimination of water-soluble solutes. This is not the case for the middle molecule beta M-2 and the protein-bound solute p-cresol.
引用
收藏
页码:512 / 519
页数:8
相关论文
共 38 条
[1]   Effect of fluid and sodium removal on mortality in peritoneal dialysis patients [J].
Ates, K ;
Nergizoglu, G ;
Keven, K ;
Sen, A ;
Kutlay, S ;
Ertürk, S ;
Duman, N ;
Karatan, O ;
Ertug, AE .
KIDNEY INTERNATIONAL, 2001, 60 (02) :767-776
[2]   Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms [J].
Bammens, B ;
Evenepoel, P ;
Verbeke, K ;
Vanrenterghem, Y .
KIDNEY INTERNATIONAL, 2003, 64 (06) :2238-2243
[3]  
Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158
[4]  
Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467
[5]   DYNAMICS OF ERYTHROPOIESIS FOLLOWING RENAL-TRANSPLANTATION [J].
BESARAB, A ;
CARO, J ;
JARRELL, BE ;
FRANCOS, G ;
ERSLEV, AJ .
KIDNEY INTERNATIONAL, 1987, 32 (04) :526-536
[6]  
Bouts AHM, 2000, J AM SOC NEPHROL, V11, P943, DOI 10.1681/ASN.V115943
[7]   Association between residual renal function inflammation and patient survival in new peritoneal dialysis patients [J].
Chung, SH ;
Heimbürger, O ;
Stenvinkel, P ;
Qureshi, AR ;
Lindholm, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) :590-597
[8]   Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients [J].
Davies, SJ .
KIDNEY INTERNATIONAL, 2004, 66 (06) :2437-2445
[9]   Peritoneal solute transport predicts survival on CAPD independently of residual renal function [J].
Davies, SJ ;
Phillips, L ;
Russell, GI .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (04) :962-968
[10]   Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival [J].
Davies, SJ ;
Phillips, L ;
Naish, PF ;
Russell, GI .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (06) :1085-1092